These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35716926)

  • 1. Relevant insights into onychomycosis' pathogenesis related to the effectiveness topical treatment.
    Costa PS; Mendes V; Veiga FF; Negri M; Svidzinski TIE
    Microb Pathog; 2022 Aug; 169():105640. PubMed ID: 35716926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.
    Chularojanamontri L; Pattanaprichakul P; Leeyaphan C; Suphatsathienkul P; Wongdama S; Bunyaratavej S
    Biomed Res Int; 2021; 2021():9113418. PubMed ID: 34938812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
    Dhamoon RK; Popli H; Gupta M
    Pharm Nanotechnol; 2019; 7(1):24-38. PubMed ID: 31092174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic.
    Veiga FF; Gadelha MC; da Silva MRT; Costa MI; Kischkel B; de Castro-Hoshino LV; Sato F; Baesso ML; Voidaleski MF; Vasconcellos-Pontello V; Vicente VA; Bruschi ML; Negri M; Svidzinski TIE
    Front Microbiol; 2018; 9():779. PubMed ID: 29922236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
    Brown M; Turner R; Wevrett SR
    Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and
    Lee BC; Pangeni R; Na J; Koo KT; Park JW
    Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress on the topical therapy of onychomycosis.
    Alley MR; Baker SJ; Beutner KR; Plattner J
    Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Eichenfield LF; Friedlander SF
    J Drugs Dermatol; 2017 Feb; 16(2):105-109. PubMed ID: 28300851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
    Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
    Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
    Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
    Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
    PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.